ネブライザーの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

ネブライザー市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のネブライザー市場規模は2030年までに17億7,000万米ドルに達し、2025～2030年にかけてCAGR 6.35%を記録すると推定されています。

慢性呼吸器疾患の罹患率上昇、在宅医療機器需要の増加、世界の高齢者の増加が市場成長をもたらす主要要因です。

COVID-19の大流行は世界中の数百万人に影響を及ぼしています。COVID-19の空気感染のリスクを認識していた喘息やCOPD患者は、ウイルス感染や免疫抑制の可能性があると考えられている吸入薬の使用をためらっていました。しかし、開業医はそのような患者全員に、ネブライザーを含め、配合された吸入薬を使い続けるように勧めました。米国の一部の地域では、薬局がアルブテロール吸入薬の不足に直面した際、アルブテロールレスキュー吸入薬の代替品としてネブライザーによるアルブテロール吸入が推奨されました。

COVID-19は多くの高齢者に影響を及ぼします。2020年の米国肺協会（ALA）によると、ネブライザーによる治療は、COVID-19中の患者が自宅でCOPDを管理するための安全で効果的な方法です。その結果、ネブライザーの需要が促進されます。

人口問題ラボの報告書「米国の高齢化」によると、米国の高齢者は2016年の4,800万人から2060年には9,800万人に増加すると推定されています。高齢者はCOPDや睡眠時無呼吸症候群などの呼吸器疾患にかかりやすいです。したがって、高齢者の増加は、メーカーにとっての患者プールを拡大し、市場の成長を促進すると予想されます。

また、肺への正確なドラッグデリバリーや残量の少なさから、メッシュネブライザーの商業的な受け入れが増加していることも、市場の成長を後押ししています。さらに、薬剤と装置の組み合わせなどの技術的進歩は、ネブライザー市場に新たな機会を生み出すと期待されています。

一方、ネブライゼーション中の薬剤損失は市場成長を抑制する主要要因です。しかし、薬剤の損失を抑えながら正確な薬剤投与量を実現するために製造されているため、メッシュネブライザーメーカーにとっては機会ともなり得る。

ネブライザー市場レポートハイライト

• タイプ別では、ジェットネブライザーセグメントが2024年に64.82%の最大売上シェアを占めました。
• メッシュネブライザータイプのセグメントは、技術的に先進的なコンパクトサイズのデバイスと最小限の薬剤損失により、予測期間中に有利なCAGRを示すと予想されます。
• 用途別では、慢性閉塞性肺疾患（COPD）セグメントが2024年に最大の市場シェアを占めました。COPDの世界の有病率の高さ、最近の技術進歩によるネブライザーの携帯性と使い勝手の良さによるものです。
• 2024年には、病院セグメントが67.25％の最大収益シェアを占めました。これは、有利な償還施策と患者の大きなフットフォールによるものです。
• 北米は、2024年に34.06％の最大の収益シェアを占めました。喘息、慢性閉塞性肺疾患（COPD）、気管支炎などの呼吸器疾患が流行しており、市場成長に寄与しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ネブライザー市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ネブライザー市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 新興技術の動向
  • COVID-19の影響分析

第4章 ネブライザー市場：タイプ別、推定・動向分析

• セグメントダッシュボード
• 世界のネブライザー市場のタイプ変動分析
• 世界のネブライザー市場規模と動向分析、タイプ別、2018～2030年
• ジェットネブライザー
• メッシュネブライザー
  • アクティブメッシュネブライザー
  • パッシブメッシュネブライザー
• 超音波ネブライザー

第5章 ネブライザー市場：用途別、推定・動向分析

• セグメントダッシュボード
• 世界のネブライザー市場の用途変動分析
• 世界のネブライザー市場規模と動向分析、用途別、2018～2030年
• 慢性閉塞性肺疾患
• 嚢胞性線維症
• 喘息
• その他

第6章 ネブライザー市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界のネブライザー市場の最終用途変動分析
• 世界のネブライザー市場規模と動向分析、最終用途別、2018～2030年
• 病院とクリニック
• 緊急センター
• 在宅医療

第7章 ネブライザー市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業の市場シェア/ポジション分析、2024年
• 企業プロファイル/上場企業
  • OMRON Corporation
  • GE Healthcare
  • Koninklijke Philips NV
  • Vectura Group Plc.
  • PARI Respiratory Equipment, Inc.
  • Aerogen
  • DeVilbiss Healthcare LLC
  • Beurer GmBH
  • Microlife Corporation
  • GF Health Products, Inc.
  • Rossmax International Ltd.
  • BESCO MEDICAL LIMITED
  • Bremed Ltd.

List of Tables

• Table 1 List of abbreviations
• Table 2 Global nebulizers market, by region, 2018 - 2030 (USD Million)
• Table 3 Global nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 4 Global nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 5 Global nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America nebulizers market, by country, 2018 - 2030 (USD Million)
• Table 7 North America nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 8 North America nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 9 North America nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 11 U.S. nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 17 Mexico nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe nebulizers market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 21 Europe nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 24 UK nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 25 UK nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 27 Germany nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 29 France nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 30 France nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 31 France nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 33 Italy nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 36 Spain nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 39 Denmark nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 40 Denmark nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 42 Sweden nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 44 Norway nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 45 Norway nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 46 Norway nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific nebulizers market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 51 China nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 52 China nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 53 China nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 54 Japan nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 55 Japan nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 56 Japan nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 57 India nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 58 India nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 59 India nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 60 South Korea nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 61 South Korea nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 62 South Korea nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 63 Australia nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 64 Australia nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 65 Australia nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 67 Thailand nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America nebulizers market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 71 Latin America nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 74 Brazil nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 77 Argentina nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 79 MEA nebulizers market, by country, 2018 - 2030 (USD Million)
• Table 80 MEA nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 81 MEA nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 82 MEA nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 84 South Africa nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 90 UAE nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE nebulizers market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait nebulizers market, by type, 2018 - 2030 (USD Million)
• Table 93 Kuwait nebulizers market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Nebulizers market: Market outlook
• Fig. 5 Nebulizers market: Segment outlook
• Fig. 6 Nebulizers market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Nebulizers market driver impact
• Fig. 9 Nebulizers market restraint impact
• Fig. 10 Nebulizers market: Type outlook and key takeaways
• Fig. 11 Nebulizers market: Type movement analysis
• Fig. 12 Jet nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Active mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Passive mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Ultrasonic nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Nebulizers market: Application outlook and key takeaways
• Fig. 18 Nebulizers market: Application movement analysis
• Fig. 19 COPD market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Cystic fibrosis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Nebulizers market: End use outlook and key takeaways
• Fig. 24 Nebulizers market: End use movement analysis
• Fig. 25 Hospital and Clinics market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 26 Emergency Centers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Home Healthcare market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 28 Global nebulizers market: Regional outlook and key takeaways
• Fig. 29 Global nebulizers market: Regional movement analysis
• Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Key country dynamics
• Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Key country dynamics
• Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Key country dynamics
• Fig. 36 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Key country dynamics
• Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Key country dynamics
• Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Key country dynamics
• Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Nebulizer Market Growth & Trends:

The global nebulizer market size is estimated to reach USD 1.77 billion by 2030, registering a CAGR of 6.35% from 2025 to 2030, according to a new report by Grand View Research, Inc., Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware regarding the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced shortage of albuterol inhalers.

COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. Consequently, promotes the nebulizers demand.

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

Increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth. Furthermore, Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market.

On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss.

Nebulizer Market Report Highlights:

• By type, the jet nebulizers segment held the largest revenue share of 64.82% in 2024, owing to the low cost of the devices.
• Mesh nebulizers type segment is expected to witness lucrative CAGR over the forecast period, due to the technologically advanced compact size devices and minimized drug loss.
• Based on application, the chronic obstructive pulmonary disorder (COPD) segment accounted for the largest market share in 2024, owing to the high global prevalence of COPD, recent technological advancements have made nebulizers more portable and user-friendly.
• In 2024, the hospitals segment accounted for the largest revenue share of 67.25% in 2024, owing to the favorable reimbursement policies and significant patient footfall.
• North America held the largest revenue share of 34.06% in 2024. Respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and bronchitis have become more prevalent, thereby contributing to market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Nebulizers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic respiratory diseases
    • 3.2.1.2. Growing demand for home healthcare products
    • 3.2.1.3. Increasing availability of advanced and cost-effective technologies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Drug loss during drug delivery
    • 3.2.2.2. Risk of disease transmission
    • 3.2.2.3. Stringent regulatory requirements
• 3.3. Nebulizers Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Emerging Technology Trends
  • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Nebulizers Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Nebulizers Market Type Movement Analysis
• 4.3. Global Nebulizers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Jet Nebulizer
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Mesh Nebulizer
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Active Mesh Nebulizer
    • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Passive Mesh Nebulizer
    • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Ultrasonic Nebulizer
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Nebulizers Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Nebulizers Market Application Movement Analysis
• 5.3. Global Nebulizers Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. COPD
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Cystic Fibrosis
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Asthma
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. ebulizers Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Nebulizers Market End Use Movement Analysis
• 6.3. Global Nebulizers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospital and Clinics
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Emergency Centers
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Home Healthcare
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Nebulizers Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Share/Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. OMRON Corporation
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. GE Healthcare
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Koninklijke Philips N.V.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Vectura Group Plc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. PARI Respiratory Equipment, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Aerogen
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. DeVilbiss Healthcare LLC
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Beurer GmBH
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Microlife Corporation
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. GF Health Products, Inc.,
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Rossmax International Ltd.
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. BESCO MEDICAL LIMITED
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Bremed Ltd.
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives